High TIL infiltration, especially CD8+ T‐cells, generally correlates with improved outcomes such as in endometrial cancer (especially the POLE‐ultramutated subgroup), invasive breast cancer, and ovarian epithelial tumors. The gene discussed is CD8A; the disease is invasive breast carcinoma.